HIKMA PHARMS FDA Approval ANDA 060770

ANDA 060770

HIKMA PHARMS

FDA Drug Application

Application #060770

Application Sponsors

ANDA 060770HIKMA PHARMS

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORALEQ 250MG BASE0OXYTETRACYCLINE HYDROCHLORIDEOXYTETRACYCLINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1967-09-29
LABELING; LabelingSUPPL2AP1990-12-10
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1991-06-11

Submissions Property Types

SUPPL3Null0

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 60770
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXYTETRACYCLINE HYDROCHLORIDE","activeIngredients":"OXYTETRACYCLINE HYDROCHLORIDE","strength":"EQ 250MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"OXYTETRACYCLINE HYDROCHLORIDE","submission":"OXYTETRACYCLINE HYDROCHLORIDE","actionType":"EQ 250MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.